In June, pharmaphorum came together with the Connected World Without Disease Accelerator for the inaugural World Without Disease Summit, a two-day event that brought together stakeholders f
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<
